ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2262

Evaluation of Illness Perception in Systemic Sclerosis Patients with Pulmonary Involvement

Bruna Giusto Bunjes1, Percival Degrava Sampaio-Barros 2 and Ana Paula Luppino-Assad 3, 11- Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Sao Paulo, Brazil, 2Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR, Brazil, Sao Paulo, Brazil, 3Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Sao Paulo, Brazil

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: disability and HAQ, Illness Perception, quality of life, Systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Patient Outcomes, Preferences, & Attitudes Poster II: Patient Preferences, Beliefs, & Experiences

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Lung disease is the current leading cause of death and the most common severe complication of systemic sclerosis (SSc), causing a significant adverse impact in quality of life. Due to its severity in the context of SSc, we decided to focus on SSc patients with pulmonary involvement to determine their perception about the disease and correlate with quality of life, degree of disability and symptoms, as well as expectations.

Methods: This cross-sectional study included SSc patients with symptomatic lung involvement who signed an informed consent. Demographic, clinical and laboratory information were collected from an electronic register database. Revised Illness Perception Questionnaire (IPQR), 36-Item Short Form Health Survey (SF-36), Health Assessment Questionnaire Disability index (HAQDI), COPD Assessment Test (CAT) and three direct questions regarding quality of life, expectations about treatment and survival were applied to patients. IPQR score have negative domains (higher score means negative perception) and positive domains (higher score means positive perception). Correlations between questionnaires were made to evaluate patient perception measured by IPQR and if those perceptions would affect their opinion.

Results: 130 consecutive SSc patients were included, 55 (42%) with limited SSc, 64 (49%) diffuse and 11 (8%) sine scleroderma. Mean age was 54±12.5 years and mean disease duration 12±9 years.  All domains of IPQR statistically correlated with SF36, HAQ and CAT, except the perception of chronicity. The Pearson linear correlation was negative between SF36 and negative IPQR domains (meaning worse quality of life and higher negative perception); and positive between SF36 and positive domains (meaning higher quality of life and higher positive perception). Higher HAQ and CAT indicated higher disability and dyspnea, presenting a linear positive Pearson correlation (p< 0.0001) (Table 1).   A higher perception score was found comparing patients with moderate to severe disability (HAQ >1.25) or advanced dyspnea scores (CAT > 20) to patients with lower grade of disability or pulmonary symptoms. (Table 2). The relation between age, disease duration and IPQR had no statistical significance.  Regarding the subjective opinion of the patients, established by direct questions, they presented optimistic answers as such 86.9% classified their quality of life as good, 45% expected cure or improvement with treatment in progress, and 85% believed that they would live more than 5 years. But no correlation between the IPQR domains and their opinion was found.

Conclusion: SSc patients with impaired quality of life, disability and major symptoms of dyspnea have higher perception of their disease by IPQR. However, the degree of perception does not appear to influence their opinion, suggesting an optimistic psychological profile with more positive attitude and effective coping strategies.


Table 1


Table 2


Disclosure: B. Bunjes, None; P. Sampaio-Barros, None; A. Luppino-Assad, None.

To cite this abstract in AMA style:

Bunjes B, Sampaio-Barros P, Luppino-Assad A. Evaluation of Illness Perception in Systemic Sclerosis Patients with Pulmonary Involvement [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/evaluation-of-illness-perception-in-systemic-sclerosis-patients-with-pulmonary-involvement/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-illness-perception-in-systemic-sclerosis-patients-with-pulmonary-involvement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology